Related Experiment Videos
[Conjugate vaccines]
1Unité d'Epidémiologie pédiatrique et Vaccination, Ecole de Santé publique, U.L.B.
Insights
Conjugate vaccines provide crucial protection for young children against serious infections like Haemophilus influenzae type b and pneumococcal disease. This review examines their effectiveness, focusing on immune response, protection surrogates, and herd immunity.
Area of Science:
- Immunology
- Vaccinology
- Pediatric Infectious Diseases
Context:
- Conjugate vaccines have revolutionized pediatric immunization, extending protection to diseases previously difficult to prevent in infants.
- These vaccines convert T-independent antigens into T-dependent ones, enabling immune responses in children under two years old.
Purpose:
- To review the efficacy and immunological principles of three key conjugate vaccines.
- To address critical questions regarding antigen interference, serological correlates of protection, herd immunity, and serotype replacement.
Summary:
- Conjugating capsular polysaccharides to carrier proteins enhances immunogenicity, providing protection against Haemophilus influenzae type b, Neisseria meningitidis serogroup C, and Streptococcus pneumoniae.
- The review explores challenges such as antigenic interference and discusses the concept of serological surrogates for vaccine efficacy.
- It also examines the broader public health implications, including herd immunity and the potential for serotype replacement.
Impact:
- Conjugate vaccines significantly reduce the burden of invasive bacterial infections in children, improving child survival rates.
- Understanding immune responses and epidemiological effects is vital for optimizing vaccination strategies and combating infectious diseases.
Abstract:
Conjugate vaccines extend the vaccinal prevention for children to more diseases. Conjugating the capsular polysaccharide to a carrier protein transforms a T-independent antigen in a T-dependent, allowing protection of the children (before 2 years of age) against Haemophilus influenzae type b, meningococcal C and pneumococcal infections. This article reviews the 3 conjugate vaccines and their results with focus on some questions: antigens interference in the immunological response, serological subrogate for protection, herd immunity and replacement of circulating serotypes.